Eiji Kashiwagi Selected Research

2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamine

1/2020	Compound A inhibits urothelial tumorigenesis via both the androgen receptor and glucocorticoid receptor signaling pathways.
10/2015	Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eiji Kashiwagi Research Topics

Disease

63	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 02/2011
36	Neoplasms (Cancer) 05/2022 - 01/2008
21	Urinary Bladder Neoplasms (Bladder Cancer) 02/2021 - 07/2012
6	Carcinogenesis 01/2020 - 06/2013
6	Carcinoma (Carcinomatosis) 11/2016 - 08/2014
3	Hypertension (High Blood Pressure) 11/2019 - 05/2017
3	Obesity 05/2017 - 11/2015
2	Inflammation (Inflammations) 01/2022 - 06/2016
2	Non-Muscle Invasive Bladder Neoplasms 10/2021 - 06/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2014
2	Diabetes Mellitus 12/2019 - 05/2017
2	Dyslipidemias (Dyslipidemia) 12/2019 - 05/2017
2	Overweight 11/2018 - 05/2017
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2017 - 01/2015
2	Sarcoma (Soft Tissue Sarcoma) 02/2016 - 05/2015
1	Margins of Excision 01/2022
1	False Aneurysm (Pseudoaneurysm) 01/2021
1	Angiomyolipoma 11/2020
1	Tuberous Sclerosis (Bourneville's Disease) 11/2020
1	Virus Diseases (Viral Diseases) 01/2020

Drug/Important Bio-Agent (IBA)

39	AndrogensIBA 02/2022 - 02/2011
37	Androgen Receptors (Androgen Receptor)IBA 05/2022 - 02/2011
14	enzalutamideIBA 05/2022 - 02/2014
9	Testosterone (Sustanon)FDA Link 10/2022 - 11/2015
9	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 05/2010
9	Proteins (Proteins, Gene)FDA Link 08/2016 - 10/2008
8	Docetaxel (Taxotere)FDA Link 03/2022 - 09/2013
7	Hormones (Hormone)IBA 03/2022 - 09/2013
7	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2014
7	Biological ProductsIBA 08/2016 - 01/2008
5	abirateroneIBA 03/2022 - 12/2020
5	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2011
5	CarcinogensIBA 01/2021 - 02/2016
5	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 08/2014
5	Messenger RNA (mRNA)IBA 08/2016 - 07/2011
4	Androgen Antagonists (Antiandrogens)IBA 05/2022 - 10/2016
4	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 12/2010
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 02/2011
4	Estrogen ReceptorsIBA 01/2020 - 11/2016
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2010
4	hydroxyflutamideIBA 01/2020 - 10/2015
4	Pharmaceutical PreparationsIBA 07/2018 - 12/2010
3	bicalutamide (Casodex)FDA LinkGeneric 12/2020 - 10/2016
3	Estrogens (Estrogen)FDA Link 01/2020 - 01/2019
3	Gemcitabine FDA Link 01/2020 - 01/2015
3	Dihydrotestosterone (Androstanolone)IBA 01/2020 - 10/2015
3	Prostaglandin Receptors (Prostaglandin Receptor)IBA 01/2020 - 06/2013
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 08/2014
3	GlucocorticoidsIBA 12/2019 - 08/2014
3	taxaneIBA 01/2019 - 09/2013
3	Taxoids (Taxanes)IBA 10/2018 - 09/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 05/2018 - 08/2014
3	Therapeutic UsesIBA 07/2016 - 09/2013
3	Protein Isoforms (Isoforms)IBA 02/2016 - 06/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2016 - 01/2015
3	Tacrolimus (Prograf)FDA LinkGeneric 02/2016 - 01/2015
2	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 05/2022 - 06/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2021 - 06/2019
2	trans-sodium crocetinate (crocetin)IBA 11/2020 - 01/2019
2	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 01/2020 - 10/2015
2	Flutamide (Eulexin)FDA LinkGeneric 01/2020 - 10/2016
2	LigandsIBA 01/2020 - 10/2015
2	MethylcholanthreneIBA 12/2019 - 02/2016
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019 - 01/2018
2	Cyclin D1IBA 01/2017 - 02/2016
2	Cyclin EIBA 01/2017 - 02/2016
2	Protein Kinase CIBA 01/2017 - 02/2014
2	silodosin FDA Link 06/2016 - 01/2015
2	RNA (Ribonucleic Acid)IBA 05/2015 - 01/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2015 - 01/2015
2	SL0101IBA 06/2014 - 06/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 12/2010
2	AntioxidantsIBA 02/2012 - 10/2008
2	PeroxiredoxinsIBA 07/2011 - 10/2008
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 07/2011 - 10/2008
1	Indicators and Reagents (Reagents)IBA 10/2022
1	Radium-223IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2021
1	MTOR InhibitorsIBA 11/2020
1	TOR Serine-Threonine KinasesIBA 11/2020
1	ButylhydroxybutylnitrosamineIBA 01/2020
1	serotonin 5 receptorIBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	Enzyme Precursors (Zymogens)IBA 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	Adiponectin ReceptorsIBA 01/2020

Therapy/Procedure

36	Castration 05/2022 - 07/2011
35	Therapeutics 05/2022 - 01/2008
10	Prostatectomy (Retropubic Prostatectomy) 10/2022 - 05/2015
8	Drug Therapy (Chemotherapy) 03/2022 - 05/2010
3	Radiotherapy 04/2021 - 10/2017
3	Neoadjuvant Therapy 09/2020 - 01/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 11/2018
2	Operative Surgical Procedures 05/2017 - 07/2013
1	Drug Tapering 03/2022
1	Precision Medicine 02/2022
1	Heavy Ion Radiotherapy 04/2021
1	Sternotomy 01/2021
1	Emergency Treatment 11/2020